Fact CheckerSign in

NCT07604012Not yet recruiting

Holistic Lifestyle mHealth Intervention for Risk Reduction of Type 2 Diabetes Mellitus in Young Adults

Effectiveness of Holistic Lifestyle mHealth Intervention for Risk Reduction of Type 2 Diabetes Mellitus in Young Adults: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 22 May 2026

Brief summary (registry, in English)

The goal of this clinical trial (randomized controlled trial) is to examine the effectiveness of a holistic lifestyle mHealth intervention in reducing the risk of type 2 diabetes mellitus. The study focuses on young adults aged 20-35 years, recruited from public and private universities in Rawalpindi and Islamabad, who meet the defined inclusion criteria. The main questions it aims to answer are: Does a holistic lifestyle mHealth intervention significantly reduce the risk of type 2 diabetes ? Does the intervention improve overall health-related quality of life and lifestyle behaviors, including diet, physical activity, and stress management?

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
26 Apr 2026
Start date
May 2026
Primary completion date
Jul 2026
Lead sponsor
Fatima Jinnah Women University
NCT number
NCT07604012

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From May 2026 to the primary completion date, Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Individuals diagnosed with chronic mental or physical illnesses
  • Individuals who are already taking part in an equivalent diabetes or health programme.

Other

  • Individuals with hearing or vision loss so severe that they could not access the mobile health intervention.
  • Pregnant women or women who plan on becoming pregnant during the study.
  • Individuals who are not willing to provide consent.

Who the study is looking for

  • Young adults aged between 20-35 years, as defined by the WHO.
  • At risk of diabetes based on self-reported family history or lifestyle habits.
  • Participants who are willing to engage in the mHealth intervention program.
  • Own a smartphone and are familiar with using mobile apps.
  • Complete the informed consent process, agreeing to follow the study protocol, including survey completion and health assessment.

Age in the registry: 20 years to 35 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University
Coordinator of this site? Confirm its status
RawalpindiPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.